A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

NCT03429192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2653

Last updated 2018-05-21

No results posted yet for this study

Summary

A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases

Conditions

Interventions

PROCEDURE

Surgery

Surgeries plus dissection of lymph nodes

Sponsors & Collaborators

  • LinkDoc Technology (Beijing) Co. Ltd.

    collaborator INDUSTRY
  • Tianjin Chest Hospital

    lead OTHER

Principal Investigators

  • Xun Zhang, PhD · Tianjin Chest Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-03-30
Completion
2018-03-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429192 on ClinicalTrials.gov